Westfield Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.75M | Sell |
25,990
-1,084
| -4% | -$72.2K | 0.01% | 257 |
|
|
2026
Q1 | $1.7M | Sell |
27,074
-1,412,615
| -98% | -$98.4M | 0.01% | 221 |
|
|
2025
Q4 | $95.6M | Sell |
1,439,689
-872,521
| -38% | -$56.4M | 0.4% | 75 |
|
|
2025
Q3 | $156M | Sell |
2,312,210
-68,028
| -3% | -$5.38M | 0.65% | 38 |
|
|
2025
Q2 | $208M | Sell |
2,380,238
-67,505
| -3% | -$5.29M | 0.87% | 23 |
|
|
2025
Q1 | $167M | Buy |
2,447,743
+102,142
| +4% | +$8.34M | 0.81% | 25 |
|
|
2024
Q4 | $182M | Sell |
2,345,601
-496,456
| -17% | -$36.8M | 0.79% | 23 |
|
|
2024
Q3 | $191M | Buy |
2,842,057
+876,739
| +45% | +$72M | 0.86% | 21 |
|
|
2024
Q2 | $223M | Buy |
1,965,318
+425,857
| +28% | +$53.8M | 1.09% | 14 |
|
|
2024
Q1 | $214M | Sell |
1,539,461
-317,825
| -17% | -$40M | 1.12% | 14 |
|
|
2023
Q4 | $230M | Buy |
1,857,286
+9,421
| +0.5% | +$962K | 1.34% | 11 |
|
|
2023
Q3 | $172M | Buy |
1,847,865
+817,351
| +79% | +$92.1M | 1.17% | 11 |
|
|
2023
Q2 | $132M | Sell |
1,030,514
-539,981
| -34% | -$65.3M | 0.84% | 26 |
|
|
2023
Q1 | $182M | Buy |
1,570,495
+52,048
| +3% | +$5.83M | 1.29% | 13 |
|
|
2022
Q4 | $172M | Sell |
1,518,447
-377,132
| -20% | -$41.4M | 1.33% | 10 |
|
|
2022
Q3 | $153M | Buy |
1,895,579
+16,470
| +0.9% | +$1.39M | 1.21% | 11 |
|
|
2022
Q2 | $140M | Buy |
1,879,109
+255,825
| +16% | +$23.3M | 1.1% | 13 |
|
|
2022
Q1 | $208M | Buy |
1,623,284
+741,588
| +84% | +$81.1M | 1.33% | 11 |
|
|
2021
Q4 | $118M | Buy |
881,696
+407,080
| +86% | +$58.5M | 0.7% | 41 |
|
|
2021
Q3 | $64.9M | Sell |
474,616
-310,320
| -40% | -$39.1M | 0.39% | 90 |
|
|
2021
Q2 | $83.8M | Sell |
784,936
-270,864
| -26% | -$26M | 0.5% | 68 |
|
|
2021
Q1 | $94.9M | Buy |
1,055,800
+391,784
| +59% | +$36.8M | 0.59% | 56 |
|
|
2020
Q4 | $61.4M | Sell |
664,016
-10,056
| -1% | -$898K | 0.36% | 99 |
|
|
2020
Q3 | $69.5M | Buy |
674,072
+38,480
| +6% | +$4.02M | 0.45% | 71 |
|
|
2020
Q2 | $64.4M | Sell |
635,592
-1,371,556
| -68% | -$123M | 0.44% | 76 |
|
|
2020
Q1 | $135M | Sell |
2,007,148
-441,348
| -18% | -$27.5M | 1.19% | 20 |
|
|
2019
Q4 | $134M | Buy |
2,448,496
+122,684
| +5% | +$5.82M | 0.95% | 27 |
|
|
2019
Q3 | $86.8M | Buy |
2,325,812
+1,339,092
| +136% | +$52M | 0.69% | 46 |
|
|
2019
Q2 | $37M | Buy |
986,720
+310,288
| +46% | +$9.75M | 0.28% | 121 |
|
|
2019
Q1 | $20.1M | Sell |
676,432
-551,320
| -45% | -$19.4M | 0.15% | 174 |
|
|
2018
Q4 | $36.8M | Buy |
1,227,752
+676,584
| +123% | +$21.5M | 0.31% | 99 |
|
|
2018
Q3 | $19.7M | Buy |
+551,168
| New | +$17.1M | 0.14% | 181 |
|
|
2017
Q4 | – | Sell |
-1,993,800
| Closed | -$24.4M | – | 248 |
|
|
2017
Q3 | $24.4M | Sell |
1,993,800
-1,656,800
| -45% | -$29.3M | 0.19% | 169 |
|
|
2017
Q2 | $66.8M | Buy |
3,650,600
+1,041,236
| +40% | +$19.2M | 0.57% | 60 |
|
|
2017
Q1 | $55.3M | Sell |
2,609,364
-385,820
| -13% | -$7.53M | 0.47% | 74 |
|
|
2016
Q4 | $44.7M | Buy |
2,995,184
+986,080
| +49% | +$17.5M | 0.39% | 95 |
|
|
2016
Q3 | $44M | Sell |
2,009,104
-830,900
| -29% | -$18.5M | 0.36% | 94 |
|
|
2016
Q2 | $56.3M | Buy |
2,840,004
+2,163,132
| +320% | +$36.8M | 0.46% | 73 |
|
|
2016
Q1 | $11.5M | Buy |
676,872
+666,572
| +6,472% | +$11.1M | 0.09% | 191 |
|
|
2015
Q4 | $211K | Buy |
+10,300
| New | +$214K | ﹤0.01% | 272 |
|
|
2013
Q3 | – | Sell |
-2,290,840
| Closed | -$12.9M | – | 357 |
|
|
2013
Q2 | $12.9M | Buy |
+2,290,840
| New | +$11M | 0.09% | 234 |
|
Other funds holding DXCM
Westfield Capital Management's DXCM Position: Q2 2026 in Review
Westfield Capital Management reduced its DexCom (DXCM) stake by 4% in Q2 2026, selling an estimated $72.2K and leaving 25,990 shares worth $1.75M. The position accounts for 0.01% of the portfolio, ranked #257.
Westfield Capital Management first reported a position in DXCM in Q2 2013 and has held it in 41 quarters since. The position peaked at $230M in Q4 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Westfield Capital Management held 25,990 shares of DexCom worth $1.75M as of Q2 2026.
- Westfield Capital Management sold 1,084 DexCom shares in Q2 2026, an estimated $72.2K.
- DexCom made up 0.01% of Westfield Capital Management's portfolio in Q2 2026, its #257 holding.
- Westfield Capital Management first reported a position in DexCom in Q2 2013 and has held it in 41 quarters since.
- Westfield Capital Management's DexCom position peaked at $230M in Q4 2023.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.